Literature DB >> 26780251

The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.

Jean-Philippe Loeffler1,2, Gina Picchiarelli1,2, Luc Dupuis1,2, Jose-Luis Gonzalez De Aguilar1,2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset disease primarily characterized by upper and lower motor neuron degeneration, muscle wasting and paralysis. It is increasingly accepted that the pathological process leading to ALS is the result of multiple disease mechanisms that operate within motor neurons and other cell types both inside and outside the central nervous system. The implication of skeletal muscle has been the subject of a number of studies conducted on patients and related animal models. In this review, we describe the features of ALS muscle pathology and discuss on the contribution of muscle to the pathological process. We also give an overview of the therapeutic strategies proposed to alleviate muscle pathology or to deliver curative agents to motor neurons. ALS muscle mainly suffers from oxidative stress, mitochondrial dysfunction and bioenergetic disturbances. However, the way by which the disease affects different types of myofibers depends on their contractile and metabolic features. Although the implication of muscle in nourishing the degenerative process is still debated, there is compelling evidence suggesting that it may play a critical role. Detailed understanding of the muscle pathology in ALS could, therefore, lead to the identification of new therapeutic targets.
© 2016 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Entities:  

Keywords:  Cu/Zn-superoxide dismutase; amyotrophic lateral sclerosis; energy metabolism; mitochondria; oxidative stress; skeletal muscle

Mesh:

Year:  2016        PMID: 26780251     DOI: 10.1111/bpa.12350

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  55 in total

1.  ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression.

Authors:  Yajuan Xiao; Chehade Karam; Jianxun Yi; Lin Zhang; Xuejun Li; Dosuk Yoon; Huan Wang; Kamal Dhakal; Paul Ramlow; Tian Yu; Zhaohui Mo; Jianjie Ma; Jingsong Zhou
Journal:  Pharmacol Res       Date:  2018-09-18       Impact factor: 7.658

2.  Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle.

Authors:  Sonja Prpar Mihevc; Mojca Pavlin; Simona Darovic; Marko Živin; Matej Podbregar; Boris Rogelj; Tomaz Mars
Journal:  J Mol Neurosci       Date:  2017-06-15       Impact factor: 3.444

3.  Two distinct skeletal muscle microRNA signatures revealing the complex mechanism of sporadic ALS.

Authors:  Evrim Aksu-Menges; Burcu Balci-Hayta; Can Ebru Bekircan-Kurt; Ayse Tulay Aydinoglu; Sevim Erdem-Ozdamar; Ersin Tan
Journal:  Acta Neurol Belg       Date:  2021-07-09       Impact factor: 2.396

4.  Homeostatic plasticity can be induced and expressed to restore synaptic strength at neuromuscular junctions undergoing ALS-related degeneration.

Authors:  Sarah Perry; Yifu Han; Anushka Das; Dion Dickman
Journal:  Hum Mol Genet       Date:  2017-11-01       Impact factor: 6.150

5.  Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS.

Authors:  Emiliano Trias; Sofía Ibarburu; Romina Barreto-Núñez; Valentina Varela; Ivan C Moura; Patrice Dubreuil; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  JCI Insight       Date:  2017-10-19

6.  The Expanding Clinical Universe of Polyglutamine Disease.

Authors:  Shanshan Huang; Suiqiang Zhu; Xiao-Jiang Li; Shihua Li
Journal:  Neuroscientist       Date:  2019-01-07       Impact factor: 7.519

7.  Estimating Myofiber Size With Electrical Impedance Myography: a Study In Amyotrophic Lateral Sclerosis MICE.

Authors:  Kush Kapur; Janice A Nagy; Rebecca S Taylor; Benjamin Sanchez; Seward B Rutkove
Journal:  Muscle Nerve       Date:  2018-09-02       Impact factor: 3.217

Review 8.  Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model.

Authors:  Jingsong Zhou; Ang Li; Xuejun Li; Jianxun Yi
Journal:  Arch Biochem Biophys       Date:  2019-01-22       Impact factor: 4.013

Review 9.  Using Xenopus oocytes in neurological disease drug discovery.

Authors:  Steven L Zeng; Leland C Sudlow; Mikhail Y Berezin
Journal:  Expert Opin Drug Discov       Date:  2019-11-01       Impact factor: 6.098

Review 10.  The effects of diet and sex in amyotrophic lateral sclerosis.

Authors:  J A Pape; J H Grose
Journal:  Rev Neurol (Paris)       Date:  2020-03-05       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.